Lingyuan Xu
- Molecular Biology
- Pathology and Forensic Medicine top 10%
- Endocrinology, Diabetes and Metabolism top 10%
- Epidemiology
- Pharmacology top 5%
- Topics
- Liver Disease Diagnosis and Treatment (5 papers)Drug-Induced Hepatotoxicity and Protection (4 papers)Liver physiology and pathology (3 papers)
- Partner nations
- China
In The Last Decade
Lingyuan Xu
16 papers receiving 685 citations
Peers
Comparison fields: 5 of 83
- Molecular Biology 225
- Pathology and Forensic Medicine 164
- Endocrinology, Diabetes and Metabolism 158
- Epidemiology 134
- Pharmacology 132
Countries citing papers authored by Lingyuan Xu
This map shows the geographic impact of Lingyuan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingyuan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingyuan Xu more than expected).
Fields of papers citing papers by Lingyuan Xu
This network shows the impact of papers produced by Lingyuan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingyuan Xu. The network helps show where Lingyuan Xu may publish in the future.
Co-authorship network of co-authors of Lingyuan Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Lingyuan Xu. A scholar is included among the top collaborators of Lingyuan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingyuan Xu. Lingyuan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 7 | |
| 3 | 10 | |
| 4 | 43 | |
| 5 | Experimental Study of Reversion of Puerariae Radix Lobatae Flavonoids on Pancreas Injury Induced by Streptozotocin in Mice | 1 |
| 6 | 52 | |
| 7 | 26 | |
| 8 | 83 | |
| 9 | 73 | |
| 10 | 40 | |
| 11 | 67 | |
| 12 | 32 | |
| 13 | 50 | |
| 14 | 41 | |
| 15 | 71 | |
| 16 | 89 |
About Lingyuan Xu
Lingyuan Xu is a scholar working on Pharmacology, Hepatology and Speech and Hearing, having authored 16 papers that have together received 689 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (5 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Liver physiology and pathology (3 papers). The work is most often cited by research in Pharmacology (132 citations), Biochemistry (64 citations) and Complementary and alternative medicine (79 citations). Lingyuan Xu has collaborated with scholars based in China. Frequent co-authors include Tao Liang, Xiaoqun Duan, Rong Li, Qiaoling He, Kefeng Zhang, Ni Zheng, Rong Li, Chao Guo, Chao Guo and Shijun Zhang. Their work appears in journals such as Brain Research, Carbohydrate Polymers and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.